Search

everythinglearnresearchcommunity

for

Search:↓

An 84-year-old man developed severe anemia after his first COVID-19 vaccine shot, improved with treatment, and was advised against a second dose.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

Sex hormones' effects on COVID-19 are unclear and more research is needed to understand their potential as treatment.

Dermatologists helped identify COVID-19 through skin symptoms and managed skin issues during the pandemic, but more high-quality research is needed.

Most children recovered from COVID-19 in 4 weeks, but some experienced long-term symptoms, especially older kids.

Finasteride may help reduce COVID-19 infection by altering a key gene.

Countries with stricter cultures had fewer COVID-19 cases and deaths, paranoia is linked to false memories, psychosocial intervention works as well with or without antipsychotic drugs for young people with psychosis, smartphones can detect changes in behavior indicating illness relapse, and recruitment agents show regional and gender biases.

Some people who recover from COVID-19 continue to have symptoms like fatigue and cough for over 120 days, and some experience hair loss about 59 days after getting sick.

A woman's sudden hair loss was linked to her previous COVID-19 infection.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

Possible link between androgens and COVID-19 severity; more research needed.

People with no symptoms or mild COVID-19 have lower antibody levels, increasing their risk of getting COVID-19 again.

Men may be more vulnerable to severe COVID-19 due to genetic and hormonal factors, but more research is needed.

Hair loss occurred after a COVID-19 infection.

MSC-derived exosomes can help treat COVID-19, hair loss, skin aging, and arthritis.

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

Skin and mucosal issues can occur after COVID-19 in adults and children.

The editorial stresses the importance of COVID-19 vaccination and ongoing contributions to the journal.

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

5-alpha reductase inhibitors might worsen lung recovery in COVID-19 patients, suggesting a pause in their use.

PRP therapy can effectively treat hair loss after COVID-19 vaccination.

A man developed autoimmune symptoms after the Pfizer COVID-19 vaccine, highlighting the need for thorough vaccine safety checks.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

Nursing staff's mental health was affected during the COVID-19 pandemic.

Low testosterone levels may lead to more severe COVID-19 outcomes.

The document corrects an author's affiliation in previous articles about COVID-19 and its links to hair loss and hormones.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

The article suggests using safety measures and telemedicine for aesthetic dermatology during COVID-19, while some procedures can still be done safely.